These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

615 related articles for article (PubMed ID: 16189912)

  • 21. Clinical trials face heightened scrutiny as science and commerce appear to merge.
    Lorman AJ
    J Biolaw Bus; 2001; 4(4):23-32. PubMed ID: 12751494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Researcher liability for negligence in human subject research: informed consent and researcher malpractice actions.
    Jansson RL
    Wash Law Rev; 2003 Feb; 78(1):229-63. PubMed ID: 15732212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How institutional review boards (IRBs) can handle adverse event reports.
    Maloney DM
    Hum Res Rep; 2006 Jan; 21(1):1-3. PubMed ID: 16789305
    [No Abstract]   [Full Text] [Related]  

  • 24. Informed consent process is deemed "legally and ethically invalid" by witness.
    Maloney DM
    Hum Res Rep; 1995 Jan; 10(1):4-5. PubMed ID: 11660008
    [No Abstract]   [Full Text] [Related]  

  • 25. The role of institutional review boards in protecting human subjects: are we really ready to fix a broken system?
    Beh HG
    Law Psychol Rev; 2002; 26(1):1-47. PubMed ID: 16514756
    [No Abstract]   [Full Text] [Related]  

  • 26. Protecting research subjects--what must be done.
    Shalala D
    N Engl J Med; 2000 Sep; 343(11):808-10. PubMed ID: 10984573
    [No Abstract]   [Full Text] [Related]  

  • 27. Research administrator should not serve on institutional review board.
    Maloney DM
    Hum Res Rep; 2002 Apr; 17(4):6-7. PubMed ID: 12374181
    [No Abstract]   [Full Text] [Related]  

  • 28. IRBs and monitoring the safety of clinical trials.
    Maloney DM
    Hum Res Rep; 2003 Jan; 18(1):3. PubMed ID: 12755095
    [No Abstract]   [Full Text] [Related]  

  • 29. Human subject protections in the United States: perspectives from the Office for Protection from Research Risks.
    Russell-Einhorn M; Ellis GB
    J Biolaw Bus; 1998; 1(2):36-8. PubMed ID: 12739540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Case study: agency says institutional review board (IRB) did not fulfill duties so agency investigation expands.
    Maloney DM
    Hum Res Rep; 2006 Apr; 21(4):6-7. PubMed ID: 16832919
    [No Abstract]   [Full Text] [Related]  

  • 31. Institutional review board (IRB) violated numerous regulations.
    Maloney DM
    Hum Res Rep; 2001 Feb; 16(2):7-8. PubMed ID: 12530381
    [No Abstract]   [Full Text] [Related]  

  • 32. Institutional review boards not paying enough attention to active research projects.
    Maloney DM
    Hum Res Rep; 1998 Nov; 13(11):1-2. PubMed ID: 11657741
    [No Abstract]   [Full Text] [Related]  

  • 33. Recurrent issues in the review of medical research on human subjects.
    Moore DL
    Albany Law J Sci Technol; 1991; 1():1-33. PubMed ID: 16296123
    [No Abstract]   [Full Text] [Related]  

  • 34. Institutional review boards and the privacy of human research subjects.
    Maloney DM
    Hum Res Rep; 2002 Aug; 17(8):1-2. PubMed ID: 12731492
    [No Abstract]   [Full Text] [Related]  

  • 35. IRBs and continuing review: regulatory interference or vital safeguard?
    McBride LC; Yessian MR
    Food Drug Cosmet Med Device Law Dig; 1999 Mar; 16(1):13-7. PubMed ID: 12784812
    [No Abstract]   [Full Text] [Related]  

  • 36. Institutional review boards must conduct safety review.
    Maloney DM
    Hum Res Rep; 2005 Feb; 20(2):3. PubMed ID: 15839005
    [No Abstract]   [Full Text] [Related]  

  • 37. Regulating clinical research: informed consent, privacy, and IRBs.
    Hoffman S
    Cap Univ Law Rev; 2003; 31(1):71-91. PubMed ID: 15295833
    [No Abstract]   [Full Text] [Related]  

  • 38. Time for new rules on human subjects research?
    Dresser R
    Hastings Cent Rep; 1998; 28(6):23-4. PubMed ID: 9868606
    [No Abstract]   [Full Text] [Related]  

  • 39. Protecting vulnerable research subjects: practical realities of institutional review board review and approval.
    Wichman A
    J Health Care Law Policy; 1998; 1(1):88-104. PubMed ID: 15573431
    [No Abstract]   [Full Text] [Related]  

  • 40. Ethical oversight of research in developing countries.
    Kass N; Dawson L; Loyo-Berrios NI
    IRB; 2003; 25(2):1-10. PubMed ID: 12833901
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.